Excerpted and adapted from:
Tascilar K, Dell’Aniello S, Hudson M, et al. Statins and risk of rheumatoid arthritis: A nested case–control study. Arthritis Rheumatol. 2016 Oct;68(11):2603–2611.
Arthritis & Rheumatology |
Excerpted and adapted from:
Tascilar K, Dell’Aniello S, Hudson M, et al. Statins and risk of rheumatoid arthritis: A nested case–control study. Arthritis Rheumatol. 2016 Oct;68(11):2603–2611.
Information on safety, labeling changes, and pharmaceutical research
A recent observational study found a link between high-intensity statin therapy and a 23% reduced risk of rheumatoid arthritis. Although further research is needed, researchers note this study “provides robust evidence of a protective effect of high-intensity statins on the risk of RA.”
PHILADELPHIA—At ACR Convergence 2022, the much-anticipated ACR Review Course featured talks from eight experts. Topics reflected the heterogeneity of our field and included Sjögren’s disease, spondyloarthritis (SpA), osteoarthritis (OA), paraneoplastic rheumatic syndromes, metabolic bone disease, statin myopathy, Raynaud’s phenomenon and autoinflammatory syndrome. Here, I share highlights from this comprehensive, six-hour session. Sjögren’s Disease Sara S….
NEW YORK (Reuters Health)—Statin use is associated with an increased likelihood of developing idiopathic inflammatory myositis (IIM), researchers from Australia report. “[Although] the incidence of IIM is rare, with the increasing use of statins worldwide and the severity of this condition, this study highlights the need for increased awareness of the condition and the importance…